Literature DB >> 21530154

Validity of the memorial symptom assessment scale-short form psychological subscales in advanced cancer patients.

Katherine Webber1, Andrew N Davies.   

Abstract

CONTEXT: The Memorial Symptom Assessment Scale-Short Form (MSAS-SF) is designed to evaluate physical and psychological symptom burden in advanced cancer patients. There are no current data assessing the validity of the MSAS-SF psychological symptom scores when compared with anxiety and depression.
OBJECTIVES: This observational cross-sectional study was designed to determine the relationship between the MSAS-SF subscales and the presence of anxiety and depression.
METHODS: Advanced cancer patients attending a U.K. oncology center completed the MSAS-SF and the Hospital Anxiety and Depression Scale.
RESULTS: One hundred twenty patients participated in the study. There was an association between the presence of anxiety and depression and the MSAS-SF global distress index. There was no association between the presence of anxiety and depression and the MSAS-SF physical symptom subscale. The MSAS-SF psychological symptom subscale was more closely correlated with anxiety than depression.
CONCLUSION: These results support the validity of the MSAS-SF global distress index and psychological subscales in the assessment of patients with anxiety and depressive disorders. Copyright Â
© 2011 U.S. Cancer Pain Relief Committee. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21530154     DOI: 10.1016/j.jpainsymman.2011.02.007

Source DB:  PubMed          Journal:  J Pain Symptom Manage        ISSN: 0885-3924            Impact factor:   3.612


  7 in total

1.  Measuring health-related quality of life in patients with advanced cancer: a systematic review of self-administered measurement instruments.

Authors:  Janneke van Roij; Heidi Fransen; Lonneke van de Poll-Franse; Myrte Zijlstra; Natasja Raijmakers
Journal:  Qual Life Res       Date:  2018-02-10       Impact factor: 4.147

2.  Co-occurring Gastrointestinal Symptoms Are Associated With Taste Changes in Oncology Patients Receiving Chemotherapy.

Authors:  Alissa Nolden; Paule V Joseph; Kord M Kober; Bruce A Cooper; Steven M Paul; Marilyn J Hammer; Laura B Dunn; Yvette P Conley; Jon D Levine; Christine Miaskowski
Journal:  J Pain Symptom Manage       Date:  2019-07-23       Impact factor: 3.612

3.  The modified Memorial Symptom Assessment Scale Short Form: a modified response format and rational scoring rules.

Authors:  J L Sharp; K Gough; M C Pascoe; A Drosdowsky; V T Chang; P Schofield
Journal:  Qual Life Res       Date:  2018-05-21       Impact factor: 4.147

4.  The Effectiveness and Safety of Medical Cannabis for Treating Cancer Related Symptoms in Oncology Patients.

Authors:  Joshua Aviram; Gil M Lewitus; Yelena Vysotski; Mahmoud Abu Amna; Anton Ouryvaev; Shiri Procaccia; Idan Cohen; Anca Leibovici; Luiza Akria; Dimitry Goncharov; Neomi Mativ; Avia Kauffman; Ayelet Shai; Gil Bar-Sela; David Meiri
Journal:  Front Pain Res (Lausanne)       Date:  2022-05-20

5.  Age, time living with diagnosed HIV infection, and self-rated health.

Authors:  J A McGowan; L Sherr; A J Rodger; M Fisher; A Miners; J Anderson; M A Johnson; J Elford; S Collins; G Hart; A N Phillips; A Speakman; F C Lampe
Journal:  HIV Med       Date:  2016-07-07       Impact factor: 3.180

6.  Psychometric Properties of the Thai Version of Supportive Care Needs Survey-Partners and Caregivers (T- SCNS-P&C) for Cholangiocarcinoma Caregivers.

Authors:  Monthida Sangruangake; Ueamporn Summart; Nonglak Methakanjanasak; Piches Ruangsuksud; Metha Songthamwat
Journal:  Asian Pac J Cancer Prev       Date:  2022-03-01

7.  High pre- and postoperative symptom burden in non-responders to total knee arthroplasty.

Authors:  Maren Falch Lindberg; Turid Undebakke Schweitz; Arild Aamodt; Caryl Gay; Anners Lerdal
Journal:  PLoS One       Date:  2020-05-28       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.